Optimizing human apyrase to treat arterial thrombosis and limit reperfusion injury without increasing bleeding risk
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Optimizing human apyrase to treat arterial thrombosis and limit reperfusion injury without increasing bleeding risk
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 6, Issue 248, Pages 248ra105-248ra105
Publisher
American Association for the Advancement of Science (AAAS)
Online
2014-08-07
DOI
10.1126/scitranslmed.3009246
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Executive Summary: Heart Disease and Stroke Statistics—2013 Update
- (2013) Alan S. Go et al. CIRCULATION
- Transgenic swine: Expression of human CD39 protects against myocardial injury
- (2012) Debra G. Wheeler et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- No-Reflow Phenomenon: Maintaining Vascular Integrity
- (2011) Robert A. Kloner JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Transgenic over expression of ectonucleotide triphosphate diphosphohydrolase-1 protects against murine myocardial ischemic injury
- (2011) Ming Cai et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- The GDA1_CD39 superfamily: NTPDases with diverse functions
- (2011) Aileen F. Knowles Purinergic Signalling
- Inhibition of vascular ectonucleotidase activities by the pro-drugs ticlopidine and clopidogrel favours platelet aggregation
- (2010) Joanna Lecka et al. BRITISH JOURNAL OF PHARMACOLOGY
- Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate
- (2010) Laurent Bonello et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update)
- (2009) Frederick G. Kushner et al. CIRCULATION
- P2Y12 inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use
- (2009) L. Wallentin EUROPEAN HEART JOURNAL
- Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial
- (2009) R. Mehran et al. EUROPEAN HEART JOURNAL
- Adenosine: An endogenous modulator of innate immune system with therapeutic potential
- (2009) Vijay Kumar et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Apyrase treatment prevents ischemia–reperfusion injury in rat lung isografts
- (2009) Seiichiro Sugimoto et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial
- (2009) Gilles Montalescot et al. LANCET
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trafficking and Intracellular ATPase Activity of Human Ecto-nucleotidase NTPDase3 and the Effect of ER-Targeted NTPDase3 on Protein Folding†
- (2008) Vasily V. Ivanenkov et al. BIOCHEMISTRY
- Effect of high glucose levels in human platelet NTPDase and 5′-nucleotidase activities
- (2008) Gilberto Inácio Lunkes et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice
- (2008) Özge Uluçkan et al. JOURNAL OF CELLULAR BIOCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation